Cargando…
Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma
Liver kinase B1 (LKB1) loss is a common occurrence in various types of human cancer, and promoter methylation has been hypothesized to be a major mechanism of LKB1 inactivation. The association between LKB1 gene promoter methylation status and tumor progression in cutaneous malignant melanoma (CMM)...
Autores principales: | Zhang, Weiming, Li, Xiao, Song, Guoxin, Luo, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530115/ https://www.ncbi.nlm.nih.gov/pubmed/28781649 http://dx.doi.org/10.3892/ol.2017.6431 |
Ejemplares similares
-
LKB1 loss cooperating with BRAF V600E promotes melanoma cell invasion and migration by up-regulation MMP-2 via PI3K/Akt/mTOR pathway
por: Zhang, Weiming, et al.
Publicado: (2017) -
Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma
por: Wang, Baihe, et al.
Publicado: (2020) -
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022) -
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
por: Sandru, Angela, et al.
Publicado: (2014) -
Distinct promoter methylation patterns of LKB1 in the hamartomatous polyps of Peutz-Jeghers syndrome and its potential in gastrointestinal malignancy prediction
por: Li, Teng, et al.
Publicado: (2020)